Clinical trial
Mode of Action of Topiramate in the Treatment of Obese Patients With and Without…
NCT00304603 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00304603 |
|---|---|
| Title | Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus |
| Official title | A Study to Evaluate the Mode of Action of Topiramate in the Treatment of Obese Subjects With and Without Type 2 Diabetes Mellitus Using DNA Samples From Subjects Who Were Randomized Within Select Previous Topiramate Studies |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Obesity, Diabetes Mellitus Type 2 |
| Intervention type | Other |
| Interventions | No intervention |
| Enrollment | 1,145 |
| Start date | Apr 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Mar 20, 2006 |
| Last update posted | Nov 28, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: